Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Permian Resources Corp (Class A) | William J. Quinn | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 6,914,410 | 0 | - | - | Common Units | |
| Permian Resources Corp (Class A) | William J. Quinn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 6,914,410 | 8,226,839 (2%) | 2% | - | Class A Common Stock | |
| Clover Health Investments Corp (Class A) | Vivek Garipalli | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 3,342,699 | 10,247,042 | - | - | Class B Common Stock | |
| Clover Health Investments Corp (Class A) | Vivek Garipalli | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 3,342,699 | 0 | - | - | Restricted Stock Unit | |
| Equillium Inc | Bruce D. Steel | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 1,750,000 | 1,750,000 | - | - | Employee Stock Option (right to buy) | |
| Clover Health Investments Corp (Class A) | Vivek Garipalli | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 1,655,949 | 3,512,196 | - | 0 | Class A Common Stock | |
| Clover Health Investments Corp (Class A) | Vivek Garipalli | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 1,655,949 | 8,591,093 | - | - | Class B Common Stock | |
| Clover Health Investments Corp (Class A) | Vivek Garipalli | Director, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.59 per share. | 07 Jan 2026 | 1,655,949 | 1,856,247 | - | 2.6 | 4,288,908 | Class A Common Stock |
| Equillium Inc | Stephen Connelly | Director, President and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 1,150,000 | 1,150,000 | - | - | Employee Stock Option (right to buy) | |
| Permian Resources Corp (Class A) | William J. Quinn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 1,018,745 | 1,018,745 (0%) | 0% | - | Class A Common Stock | |
| Permian Resources Corp (Class A) | William J. Quinn | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 1,018,745 | 0 | - | - | Common Units | |
| Cidara Therapeutics Inc | Jeffrey Stein | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 560,888 | 0 | - | - | Employee Stock Option (right to buy) | |
| MoonLake Immunotherapeutics (Class A) | Jorge Santos da Silva | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 520,342 | 520,342 | - | - | Stock Option (Right to Buy) | |
| MoonLake Immunotherapeutics (Class A) | Kristian Reich | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 520,342 | 520,342 | - | - | Stock Option (Right to Buy) | |
| Equillium Inc | Christine Zedelmayer | Sr. Vice President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 500,000 | 500,000 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Penny Tom | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 450,000 | 450,000 | - | - | Employee Stock Option (right to buy) | |
| National Bank Holdings Corp (Class A) | John Steinmetz | Exec Mng Dir of Strategic Init | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 442,132 | 442,132 (1%) | 1% | - | Common Stock | |
| National Bank Holdings Corp (Class A) | Kirk McLaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 377,982 | 377,982 (1%) | 1% | - | Common Stock | |
| National Bank Holdings Corp (Class A) | G. Timothy Laney | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 377,724 | 655,446 (2%) | 1% | - | Common Stock | |
| NewAmsterdam Pharma Co NV | Michael Harvey Davidson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 364,000 | 364,000 | - | - | Option (right to buy) | |
| MoonLake Immunotherapeutics (Class A) | Matthias Bodenstedt | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 354,296 | 1,276,305 | - | 0 | Class A ordinary shares, par value $0.0001 per share | |
| SELLAS Life Sciences Grp Inc | Dragan Cicic | SVP, Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 300,000 | 557,805 (10%) | 5% | 0 | Common Stock | |
| SELLAS Life Sciences Grp Inc | John T. Burns | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 300,000 | 554,327 (10%) | 5% | 0 | Common Stock | |
| Cidara Therapeutics Inc | Jeffrey Stein | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 275,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| MP Materials Corp | James H. Litinsky | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 64.17 per share. | 07 Jan 2026 | 272,600 | 12,805,965 | - | 64.2 | 17,492,742 | Common Stock |
| National Bank Holdings Corp (Class A) | John Steinmetz | Exec Mng Dir of Strategic Init | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 228,668 | 228,668 (0%) | 0% | - | Common Stock | |
| Netflix | Ted Sarandos | Director, Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 207,420 | 359,100 (0%) | 0% | 0 | Common Stock | |
| Netflix | Gregory K. Peters | Director, Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 207,420 | 329,560 (0%) | 0% | 0 | Common Stock | |
| National Bank Holdings Corp (Class A) | Kirk McLaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 205,204 | 583,186 (1%) | 0% | - | Common Stock | |
| Hudson Pacific Properties Inc | Victor J. Coleman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 190,476 | 577,561 | - | - | LTIP Units | |
| National Bank Holdings Corp (Class A) | Aldis Birkans | PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 189,825 | 246,423 (0%) | 0% | - | Common Stock | |
| Two Harbors Investment Corp | Nicholas Letica | Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 151,727 | 318,234 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| Connexa Sports Tech Inc | Hongyu Zhou | Director | Purchase of securities on an exchange or from another person at price $ 1.21 per share. | 07 Jan 2026 | 139,097 | 491,567 | - | 1.2 | 168,307 | Common Stock |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 135,540 | 0 | - | - | Employee Stock Option (right to buy) | |
| Allarity Therapeutics Inc | Jeremy R. Graff | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 133,333 | 381,644 | - | 0 | Common Stock | |
| Archer Aviation Inc (Class A) | Adam Goldstein | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 131,300 | 131,300 | - | - | Deferred Restricted Stock Units | |
| Jefferies Fin Grp Inc | Richard B. Handler | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Jan 2026 | 130,471 | 13,347,105 (4%) | 0% | 0 | Common Stock | |
| Jefferies Fin Grp Inc | Richard B. Handler | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Jan 2026 | 130,471 | 202,974 (0%) | 0% | 0 | Common Stock | |
| NVIDIA | Ajay K. Puri | EVP, Worldwide Field Ops | Sale of securities on an exchange or to another person at price $ 188.13 per share. | 07 Jan 2026 | 128,793 | 3,818,747 (0%) | 0% | 188.1 | 24,229,750 | Common Stock |
| Cosmos Health Inc | Grigorios Siokas | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.52 per share. | 07 Jan 2026 | 124,880 | 6,975,604 | - | 0.5 | 65,000 | Common Stock, par value $.001 |
| Frontier Grp Holdings Inc | James G. Dempsey | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 117,371 | 117,371 | - | - | Performance Stock Units | |
| Cidara Therapeutics Inc | Frank L. Karbe | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 115,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Netflix | Gregory K. Peters | Director, Co-CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 90.65 per share. | 07 Jan 2026 | 101,639 | 227,921 (0%) | 0% | 90.6 | 9,213,575 | Common Stock |
| Netflix | Ted Sarandos | Director, Co-CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 90.65 per share. | 07 Jan 2026 | 101,608 | 257,492 (0%) | 0% | 90.6 | 9,210,765 | Common Stock |
| Pure Storage Inc (Class A) | John Colgrove | Director, Chief Visionary Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Jan 2026 | 100,000 | 601,959 (0%) | 0% | 0 | Class A Common Stock | |
| Pure Storage Inc (Class A) | John Colgrove | Director, Chief Visionary Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Jan 2026 | 100,000 | 100,000 (0%) | 0% | 0 | Class A Common Stock | |
| Gyre Therapeutics Inc | Ping Zhang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Emerald Holding Inc | Herve Sedky | CEO & President | Sale or transfer of securities back to the company at price $ 4.62 per share. | 07 Jan 2026 | 96,412 | 437,427 (0%) | 0% | 4.6 | 445,423 | Common Stock |
| Proassurance Corp | Edward L. Rand | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 95,714 | 95,714 | - | - | Restricted Stock Units | |
| National Bank Holdings Corp (Class A) | John Steinmetz | Exec Mng Dir of Strategic Init | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 95,396 | 537,528 (1%) | 0% | - | Common Stock | |
| Hudson Pacific Properties Inc | Victor J. Coleman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 95,238 | 95,238 | - | - | Performance LTIP Units | |
| KLX Energy Services Holdings Inc | Keefer M. Lehner | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 94,306 | 24,895 (0%) | 0% | 0 | Common stock | |
| Emerald Holding Inc | Issa Jouaneh | President, Connections Group | Sale or transfer of securities back to the company at price $ 4.62 per share. | 07 Jan 2026 | 88,542 | 181,875 (0%) | 0% | 4.6 | 409,064 | Common Stock |
| RF Ind Ltd | Robert D. Dawson | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 87,500 | 87,500 | - | - | Stock Option (right to buy) | |
| Hudson Pacific Properties Inc | Mark T. Lammas | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 87,301 | 260,751 | - | - | LTIP Units | |
| Two Harbors Investment Corp | Rebecca B. Sandberg | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 81,699 | 238,417 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| NewAmsterdam Pharma Co NV | Michael Harvey Davidson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 81,000 | 459,859 | - | - | Ordinary Shares | |
| Warby Parker Inc (Class A) | David Gilboa | Director, Co-Chief Executive Officer | 07 Jan 2026 | 75,000 | 112,247 | - | 0 | Class A Common Stock | ||
| Warby Parker Inc (Class A) | David Gilboa | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 27.09 per share. | 07 Jan 2026 | 75,000 | 37,247 | - | 27.1 | 2,031,750 | Class A Common Stock |
| Warby Parker Inc (Class A) | David Gilboa | Director, Co-Chief Executive Officer | 07 Jan 2026 | 75,000 | 4,709,923 | - | - | Class B Common Stock | ||
| Emerald Holding Inc | David B. Doft | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 4.62 per share. | 07 Jan 2026 | 71,621 | 154,384 (0%) | 0% | 4.6 | 330,889 | Common Stock |
| NVIDIA | Ajay K. Puri | EVP, Worldwide Field Ops | Sale of securities on an exchange or to another person at price $ 187.25 per share. | 07 Jan 2026 | 71,007 | 3,947,540 (0%) | 0% | 187.3 | 13,296,153 | Common Stock |
| Netflix | Spencer Adam Neumann | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 70,260 | 107,170 (0%) | 0% | 0 | Common Stock | |
| Oklo Inc (Class A) | Jacob DeWitte | Director, Co-Founder, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 100.06 per share. | 07 Jan 2026 | 69,827 | 1,410,173 | - | 100.1 | 6,986,617 | Class A Common Stock |
| Oklo Inc (Class A) | Caroline Cochran | Director, Co-Founder, COO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 100.06 per share. | 07 Jan 2026 | 69,827 | 1,410,173 | - | 100.1 | 6,986,617 | Class A Common Stock |
| Oklo Inc (Class A) | Jacob DeWitte | Director, Co-Founder, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 100.06 per share. | 07 Jan 2026 | 69,826 | 1,410,174 | - | 100.1 | 6,986,517 | Class A Common Stock |
| Oklo Inc (Class A) | Caroline Cochran | Director, Co-Founder, COO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 100.06 per share. | 07 Jan 2026 | 69,826 | 1,410,174 | - | 100.1 | 6,986,517 | Class A Common Stock |
| Cidara Therapeutics Inc | Jeffrey Stein | Director, President & CEO | Sale or transfer of securities back to the company at price $ 221.50 per share. | 07 Jan 2026 | 67,498 | 0 (0%) | 0% | 221.5 | 14,950,807 | Common Stock |
| Cidara Therapeutics Inc | Nicole Negar Davarpanah | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 62,597 | 0 | - | - | Employee Stock Option (right to buy) | |
| MeiraGTx Holdings PLC | Alexandria Forbes | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 62,500 | 1,370,233 (3%) | 0% | - | Ordinary Shares | |
| MeiraGTx Holdings PLC | Alexandria Forbes | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 62,500 | 0 | - | - | Restricted Share Units | |
| Keros Therapeutics Inc | Jasbir Seehra | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 62,500 | 62,500 | - | - | Employee Stock Option (right to buy) | |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 100.02 per share. | 07 Jan 2026 | 53,096 | 162,957 (0%) | 0% | 100.0 | 5,310,471 | Common Stock |
| MeiraGTx Holdings PLC | Richard Giroux | CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 52,500 | 881,994 (2%) | 0% | - | Ordinary Shares | |
| MeiraGTx Holdings PLC | Richard Giroux | CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 52,500 | 0 | - | - | Restricted Share Units | |
| Cidara Therapeutics Inc | Jeffrey Stein | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 51,999 | 0 | - | - | Employee Stock Option (right to buy) | |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 51,406 | 1,094 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.45 per share. | 07 Jan 2026 | 51,406 | 192,459 (0%) | 0% | 42.5 | 2,182,185 | Common Stock |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 50,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Warby Parker Inc (Class A) | Neil Blumenthal | Director, Co-Chief Executive Officer | 07 Jan 2026 | 50,000 | 3,099,271 | - | - | Class B Common Stock | ||
| Warby Parker Inc (Class A) | Neil Blumenthal | Director, Co-Chief Executive Officer | 07 Jan 2026 | 50,000 | 87,119 | - | 0 | Class A Common Stock | ||
| Warby Parker Inc (Class A) | Neil Blumenthal | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 27.08 per share. | 07 Jan 2026 | 50,000 | 37,119 | - | 27.1 | 1,354,000 | Class A Common Stock |
| SELLAS Life Sciences Grp Inc | Jane Wasman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 50,000 | 92,900 (1%) | 0% | 0 | Common Stock | |
| SELLAS Life Sciences Grp Inc | David A. Scheinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 50,000 | 73,082 (1%) | 0% | 0 | Common Stock | |
| SELLAS Life Sciences Grp Inc | John Varian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 50,000 | 72,900 (1%) | 0% | 0 | Common Stock | |
| SELLAS Life Sciences Grp Inc | Robert L. Van Nostrand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 50,000 | 82,900 (1%) | 0% | 0 | Common Stock | |
| SELLAS Life Sciences Grp Inc | Katherine Bach Kalin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 50,000 | 154,400 (3%) | 0% | 0 | Common Stock | |
| Connexa Sports Tech Inc | Hongyu Zhou | Director | Purchase of securities on an exchange or from another person at price $ 1.03 per share. | 07 Jan 2026 | 50,000 | 352,470 | - | 1.0 | 51,500 | Common Stock |
| Peraso Inc | Robert Y. Newell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 50,000 | 53,947 | - | 0 | Common Stock | |
| Peraso Inc | Daniel Lewis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 50,000 | 54,292 | - | 0 | Common Stock | |
| Peraso Inc | Andreas Melder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 50,000 | 51,851 | - | 0 | Common Stock | |
| Gyre Therapeutics Inc | Ruoyu Chen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Zenas Biopharma Inc | Leon Oliver Moulder | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 16.38 per share. | 07 Jan 2026 | 50,000 | 316,155 | - | 16.4 | 819,000 | Common Stock |
| Two Harbors Investment Corp | William Dellal | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 46,685 | 83,388 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| Navan Inc Ordinary Shares | Benjamin A. Horowitz | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 18.11 per share. | 07 Jan 2026 | 46,337 | 8,346,792 | - | 18.1 | 839,163 | Class A Common Stock |
| Roblox Corp (Class A) | David Baszucki | Director, President & CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Jan 2026 | 46,062 | 806,254 | - | 0 | Class A Common Stock | |
| Roblox Corp (Class A) | David Baszucki | Director, President & CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Jan 2026 | 46,062 | 46,062 | - | 0 | Class A Common Stock | |
| UiPath Inc (Class A) | Daniel Dines | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 17.32 per share. | 07 Jan 2026 | 45,000 | 28,298,585 | - | 17.3 | 779,319 | Class A Commmon Stock |
| Two Harbors Investment Corp | Robert Rush | Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 44,351 | 142,558 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| RF Ind Ltd | Robert D. Dawson | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 43,750 | 345,522 (3%) | 0% | 0 | Common Stock | |
| Hudson Pacific Properties Inc | Mark T. Lammas | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 43,650 | 43,650 | - | - | Performance LTIP Units | |
| Netflix | David Hyman | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 43,500 | 359,600 (0%) | 0% | 0 | Common Stock | |
| Cidara Therapeutics Inc | Frank L. Karbe | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 43,125 | 0 (0%) | 0% | - | Common Stock | |
| Milestone Pharma Inc | Joseph G. Oliveto | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.25 per share. | 07 Jan 2026 | 43,000 | 303,721 (1%) | 0% | 2.3 | 96,750 | Common Shares |
| Intuit | Sasan K. Goodarzi | Director, CEO, President and Director | Sale of securities on an exchange or to another person at price $ 650.10 per share. | 07 Jan 2026 | 40,960 | 13,651 (0%) | 0% | 650.1 | 26,627,920 | Common Stock |
| StandardAero Inc | Russell Wayne Ford | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 30.24 per share. | 07 Jan 2026 | 40,000 | 886,955 | - | 30.2 | 1,209,548 | Common Stock |
| StandardAero Inc | Russell Wayne Ford | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 30.76 per share. | 07 Jan 2026 | 40,000 | 846,955 | - | 30.8 | 1,230,332 | Common Stock |
| National Bank Holdings Corp (Class A) | John Steinmetz | Exec Mng Dir of Strategic Init | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.33 per share. | 07 Jan 2026 | 37,668 | 499,860 (1%) | 0% | 39.3 | 1,481,482 | Common Stock |
| MeiraGTx Holdings PLC | Stuart Naylor | CHIEF DEV. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 37,500 | 0 | - | - | Restricted Share Units | |
| MeiraGTx Holdings PLC | Stuart Naylor | CHIEF DEV. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 37,500 | 660,791 (1%) | 0% | - | Ordinary Shares | |
| Emerald Holding Inc | Sara Altschul | EVP and General Counsel | Sale or transfer of securities back to the company at price $ 4.62 per share. | 07 Jan 2026 | 36,155 | 70,182 (0%) | 0% | 4.6 | 167,036 | Common Stock |
| Oklo Inc (Class A) | Jacob DeWitte | Director, Co-Founder, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 98.75 per share. | 07 Jan 2026 | 35,499 | 834,615 | - | 98.8 | 3,505,675 | Class A Common Stock |
| Oklo Inc (Class A) | Caroline Cochran | Director, Co-Founder, COO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 98.75 per share. | 07 Jan 2026 | 35,499 | 834,615 | - | 98.8 | 3,505,675 | Class A Common Stock |
| Oklo Inc (Class A) | Jacob DeWitte | Director, Co-Founder, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 98.75 per share. | 07 Jan 2026 | 35,498 | 843,789 | - | 98.8 | 3,505,577 | Class A Common Stock |
| Oklo Inc (Class A) | Caroline Cochran | Director, Co-Founder, COO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 98.75 per share. | 07 Jan 2026 | 35,498 | 843,789 | - | 98.8 | 3,505,577 | Class A Common Stock |
| Black Stone Minerals L.P. - Unit | Thomas L. Carter | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.38 per share. | 07 Jan 2026 | 34,933 | 3,477,768 (1%) | 0% | 13.4 | 467,404 | Common units representing limited partner interests |
| Green Plains Inc | Michelle S. Mapes | Chief Legal and Admin Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.80 per share. | 07 Jan 2026 | 34,906 | 33,337 (0%) | 0% | 9.8 | 342,079 | Common Stock |
| Oklo Inc (Class A) | Jacob DeWitte | Director, Co-Founder, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 97.92 per share. | 07 Jan 2026 | 34,580 | 879,287 | - | 97.9 | 3,386,036 | Class A Common Stock |
| Oklo Inc (Class A) | Caroline Cochran | Director, Co-Founder, COO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 97.92 per share. | 07 Jan 2026 | 34,580 | 879,287 | - | 97.9 | 3,386,036 | Class A Common Stock |
| Oklo Inc (Class A) | Jacob DeWitte | Director, Co-Founder, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 97.92 per share. | 07 Jan 2026 | 34,579 | 870,114 | - | 97.9 | 3,385,938 | Class A Common Stock |
| Oklo Inc (Class A) | Caroline Cochran | Director, Co-Founder, COO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 97.92 per share. | 07 Jan 2026 | 34,579 | 870,114 | - | 97.9 | 3,385,938 | Class A Common Stock |
| MeiraGTx Holdings PLC | Alexandria Forbes | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.73 per share. | 07 Jan 2026 | 34,074 | 1,336,159 (3%) | 0% | 7.7 | 263,392 | Ordinary Shares |
| Green Plains Inc | Michelle S. Mapes | Chief Legal and Admin Officer | Grant, award, or other acquisition of securities at price $ 9.80 per share. | 07 Jan 2026 | 33,904 | 67,241 (0%) | 0% | 9.8 | 332,259 | Common Stock |
| Netflix | Spencer Adam Neumann | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 90.65 per share. | 07 Jan 2026 | 33,383 | 73,787 (0%) | 0% | 90.7 | 3,026,169 | Common Stock |
| Two Harbors Investment Corp | Alecia Hanson | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 32,679 | 77,967 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| Hudson Pacific Properties Inc | Arthur Suazo | EVP, Leasing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 31,746 | 140,491 | - | - | LTIP Units | |
| Wynn Resorts | Craig Scott Billings | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 31,710 | 245,774 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| RF Ind Ltd | Peter Yin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 31,250 | 31,250 | - | - | Stock Option (right to buy) | |
| RF Ind Ltd | Ray Bibisi | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 31,250 | 31,250 | - | - | Stock Option (right to buy) | |
| TriplePoint Venture Growth BDC Corp | James P. Labe | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.43 per share. | 07 Jan 2026 | 30,877 | 1,941,857 (6%) | 0% | 6.4 | 198,570 | Common Stock |
| TriplePoint Venture Growth BDC Corp | Sajal K. Srivastava | Director, President and CIO | Purchase of securities on an exchange or from another person at price $ 6.43 per share. | 07 Jan 2026 | 30,877 | 1,941,857 (6%) | 0% | 6.4 | 198,570 | Common Stock |
| Wynn Resorts | Craig Scott Billings | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 30,312 | 300,749 (0%) | 0% | - | Common Stock, par value $0.01 per share | |
| Cidara Therapeutics Inc | Nicole Negar Davarpanah | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 30,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Zenas Biopharma Inc | Leon Oliver Moulder | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 16.30 per share. | 07 Jan 2026 | 30,000 | 346,155 | - | 16.3 | 489,000 | Common Stock |
| Terreno Realty Corp | Michael A. Coke | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 29,890 | 204,830 (0%) | 0% | 0 | Common Stock, $0.01 par value per share | |
| Terreno Realty Corp | W. Blake Baird | Director, CHAIRMAN AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 29,890 | 204,830 (0%) | 0% | 0 | Common Stock, $0.01 par value per share | |
| Lindblad Expeditions Holdings Inc | Benjamin Bressler | *Founder & CEO of NHA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.44 per share. | 07 Jan 2026 | 29,628 | 53,094 (0%) | 0% | 8.4 | 250,060 | Common Stock |
| Lindblad Expeditions Holdings Inc | Benjamin Bressler | *Founder & CEO of NHA | Sale of securities on an exchange or to another person at price $ 15.04 per share. | 07 Jan 2026 | 29,628 | 23,466 (0%) | 0% | 15.0 | 445,605 | Common Stock |
| Lindblad Expeditions Holdings Inc | Benjamin Bressler | *Founder & CEO of NHA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 29,628 | 736,600 | - | - | Stock Option (right to buy) | |
| Hudson Pacific Properties Inc | Harout K. Diramerian | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 29,620 | 84,242 | - | - | LTIP Units | |
| MeiraGTx Holdings PLC | Richard Giroux | CFO & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.73 per share. | 07 Jan 2026 | 28,822 | 853,172 (2%) | 0% | 7.7 | 222,794 | Ordinary Shares |
| Optex Systems Holdings Inc | Danny R. Schoening | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 13.44 per share. | 07 Jan 2026 | 27,946 | 825,654 | - | 13.4 | 375,594 | COMMON STOCK |
| Reddit Inc (Class A) | Benjamin Lee | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 27,930 | 152,820 | - | - | Stock Option (Right to Buy) | |
| Reddit Inc (Class A) | Benjamin Lee | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.92 per share. | 07 Jan 2026 | 27,930 | 90,538 | - | 7.9 | 221,206 | Class A Common Stock |
| MP Materials Corp | James H. Litinsky | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 64.01 per share. | 07 Jan 2026 | 27,400 | 13,078,565 | - | 64.0 | 1,753,874 | Common Stock |
| Cidara Therapeutics Inc | Jeffrey Stein | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 27,174 | 0 | - | - | Employee Stock Option (right to buy) | |
| AnaptysBio Inc | Daniel R. Faga | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 26,838 | 80,512 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Daniel R. Faga | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 26,838 | 493,625 (1%) | 0% | - | Common Stock | |
| Cidara Therapeutics Inc | Jeffrey Stein | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 26,249 | 0 | - | - | Employee Stock Option (right to buy) | |
| Optex Systems Holdings Inc | Danny R. Schoening | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 14.11 per share. | 07 Jan 2026 | 26,109 | 796,730 | - | 14.1 | 368,398 | COMMON STOCK |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 56.78 per share. | 07 Jan 2026 | 25,545 | 43,039 (0%) | 0% | 56.8 | 1,450,445 | Common Stock |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 25,545 | 2,971 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Sale of securities on an exchange or to another person at price $ 85.36 per share. | 07 Jan 2026 | 25,545 | 17,494 (0%) | 0% | 85.4 | 2,180,521 | Common Stock |
| Hudson Pacific Properties Inc | Andy Wattula | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 25,396 | 90,597 | - | - | LTIP Units | |
| Maze Therapeutics Inc | Harold S. Bernstein | President, R&D & CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.42 per share. | 07 Jan 2026 | 25,156 | 25,156 | - | 10.4 | 262,126 | Common Stock |
| Maze Therapeutics Inc | Harold S. Bernstein | President, R&D & CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 25,156 | 312,407 | - | - | Stock Option (Right to Buy) | |
| Maze Therapeutics Inc | Harold S. Bernstein | President, R&D & CMO | Sale of securities on an exchange or to another person at price $ 40.20 per share. | 07 Jan 2026 | 25,156 | 0 | - | 40.2 | 1,011,299 | Common Stock |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Sale or transfer of securities back to the company at price $ 221.50 per share. | 07 Jan 2026 | 25,083 | 0 (0%) | 0% | 221.5 | 5,555,885 | Common Stock |
| JFrog Ltd | Shlomi Ben Haim | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 59.66 per share. | 07 Jan 2026 | 25,000 | 4,766,893 | - | 59.7 | 1,491,500 | Ordinary Shares |
| Steven Madden Ltd | Amelia Newton Varela | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 24,983 | 214,682 (0%) | 0% | 0 | Common Stock par value $0.0001 per share | |
| Wynn Resorts | Craig Scott Billings | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 24,663 | 270,437 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Roblox Corp (Class A) | David Baszucki | Director, President & CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 76.22 per share. | 07 Jan 2026 | 24,514 | 21,548 | - | 76.2 | 1,868,366 | Class A Common Stock |
| Two Harbors Investment Corp | James D. Campbell | EVP Servicing Ops RoundPoint | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 24,089 | 38,748 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| Proassurance Corp | Jeffrey P. Lisenby | Executive Vice-President, Secretary & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 23,720 | 23,720 | - | - | Restricted Stock Units | |
| Proassurance Corp | Kevin M. Shook | President of a Subsidiary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 23,720 | 23,720 | - | - | Restricted Stock Units | |
| Proassurance Corp | Dana S. Hendricks | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 23,720 | 23,720 | - | - | Restricted Stock Units | |
| Proassurance Corp | Robert David Francis | Pres Healthcare Pro. Liability | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 23,720 | 23,720 | - | - | Restricted Stock Units | |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 23,594 | 119,906 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.80 per share. | 07 Jan 2026 | 23,594 | 216,053 (0%) | 0% | 29.8 | 703,101 | Common Stock |
| Flowco Holdings Inc (Class A) | Chad Roberts | EVP, Production Solutions | Sale of securities on an exchange or to another person at price $ 19.34 per share. | 07 Jan 2026 | 23,428 | 170,898 | - | 19.3 | 453,133 | Class A Common Stock |
| Roblox Corp (Class A) | David Baszucki | Director, President & CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Jan 2026 | 22,688 | 852,316 | - | 0 | Class A Common Stock | |
| Emerald Holding Inc | Danielle Puceta | EVP, Content & Commerce | Sale or transfer of securities back to the company at price $ 4.62 per share. | 07 Jan 2026 | 22,382 | 43,446 (0%) | 0% | 4.6 | 103,405 | Common Stock |
| Reddit Inc (Class A) | Benjamin Lee | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 260.10 per share. | 07 Jan 2026 | 21,680 | 68,858 | - | 260.1 | 5,638,968 | Class A Common Stock |
| Roblox Corp (Class A) | David Baszucki | Director, President & CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 76.78 per share. | 07 Jan 2026 | 21,410 | 138 | - | 76.8 | 1,643,900 | Class A Common Stock |
| Flex Ltd | Kevin S. Krumm | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 61.22 per share. | 07 Jan 2026 | 21,166 | 144,043 (0%) | 0% | 61.2 | 1,295,848 | Ordinary Shares |
| Wynn Resorts | Craig Scott Billings | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 20,916 | 0 | - | - | Performance Share Units | |
| Live Nation Entertainment | Michael Rapino | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 143.96 per share. | 07 Jan 2026 | 20,531 | 4,238,304 (1%) | 0% | 144.0 | 2,955,643 | Common Stock |
| Cidara Therapeutics Inc | Daniel D. Burgess | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 20,500 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Theodore R. Schroeder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 20,500 | 0 | - | - | Stock Option (right to buy) | |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 101.79 per share. | 07 Jan 2026 | 20,204 | 142,753 (0%) | 0% | 101.8 | 2,056,622 | Common Stock |
| Netflix | David Hyman | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 90.65 per share. | 07 Jan 2026 | 20,061 | 339,539 (0%) | 0% | 90.7 | 1,818,530 | Common Stock |
| Cidara Therapeutics Inc | Nicole Negar Davarpanah | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 20,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Zenas Biopharma Inc | Leon Oliver Moulder | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 16.55 per share. | 07 Jan 2026 | 20,000 | 366,155 | - | 16.6 | 331,000 | Common Stock |
| Warby Parker Inc (Class A) | David Gilboa | Director, Co-Chief Executive Officer | 07 Jan 2026 | 19,906 | 57,153 | - | 0 | Class A Common Stock | ||
| Warby Parker Inc (Class A) | David Gilboa | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 29.09 per share. | 07 Jan 2026 | 19,906 | 37,247 | - | 29.1 | 579,066 | Class A Common Stock |
| Warby Parker Inc (Class A) | David Gilboa | Director, Co-Chief Executive Officer | 07 Jan 2026 | 19,906 | 4,690,017 | - | - | Class B Common Stock | ||
| Allstate | Suren K. Gupta | President,Enterprise Solutions | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.32 per share. | 07 Jan 2026 | 19,593 | 120,239 (0%) | 0% | 62.3 | 1,221,036 | Common Stock |
| Allstate | Suren K. Gupta | President,Enterprise Solutions | Sale of securities on an exchange or to another person at price $ 210.00 per share. | 07 Jan 2026 | 19,593 | 100,646 (0%) | 0% | 210 | 4,114,530 | Common Stock |
| Allstate | Suren K. Gupta | President,Enterprise Solutions | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 19,593 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Cidara Therapeutics Inc | Chrysa Mineo | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 19,000 | 0 | - | - | Stock Option (right to buy) | |
| Proassurance Corp | Noreen L. Dishart | Executive VP/Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 18,477 | 18,477 | - | - | Restricted Stock Units | |
| MeiraGTx Holdings PLC | Stuart Naylor | CHIEF DEV. OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.73 per share. | 07 Jan 2026 | 17,625 | 643,166 (1%) | 0% | 7.7 | 136,241 | Ordinary Shares |
| GigaCloud Tech Inc (Class A) | Larry Lei Wu | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 41.37 per share. | 07 Jan 2026 | 17,544 | 822,456 | - | 41.4 | 725,795 | Class A Ordinary Shares, par value $0.05 per share |
| MeiraGTx Holdings PLC | Robert K. Zeldin | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 17,500 | 154,020 (0%) | 0% | - | Ordinary Shares | |
| MeiraGTx Holdings PLC | Robert K. Zeldin | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 17,500 | 0 | - | - | Restricted Share Units | |
| TriplePoint Venture Growth BDC Corp | James P. Labe | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.61 per share. | 07 Jan 2026 | 16,833 | 1,958,690 (6%) | 0% | 6.6 | 111,202 | Common Stock |
| TriplePoint Venture Growth BDC Corp | Sajal K. Srivastava | Director, President and CIO | Purchase of securities on an exchange or from another person at price $ 6.61 per share. | 07 Jan 2026 | 16,833 | 1,958,690 (6%) | 0% | 6.6 | 111,202 | Common Stock |
| Flywire Corp | Phillip J. Riese | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.59 per share. | 07 Jan 2026 | 16,612 | 251,105 | - | 0.6 | 9,801 | Voting Common Stock |
| Flywire Corp | Phillip J. Riese | Director | Sale of securities on an exchange or to another person at price $ 15.08 per share. | 07 Jan 2026 | 16,612 | 234,493 | - | 15.1 | 250,559 | Voting Common Stock |
| Flywire Corp | Phillip J. Riese | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 16,612 | 90,921 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Jeffrey Stein | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 16,499 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Jeffrey Stein | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 16,499 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Bonnie L. Bassler | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 16,000 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Carin Canale-Theakston | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 16,000 | 0 | - | - | Stock Option (right to buy) | |
| RF Ind Ltd | Peter Yin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 15,625 | 133,865 (1%) | 0% | 0 | Common Stock | |
| RF Ind Ltd | Ray Bibisi | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 15,625 | 67,542 (0%) | 0% | 0 | Common Stock | |
| GigaCloud Tech Inc (Class A) | Larry Lei Wu | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 42.48 per share. | 07 Jan 2026 | 15,579 | 840,000 | - | 42.5 | 661,811 | Class A Ordinary Shares, par value $0.05 per share |
| NewAmsterdam Pharma Co NV | Louis G. Lange | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 15,300 | 15,300 | - | - | Option (right to buy) | |
| NewAmsterdam Pharma Co NV | William H. Lewis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 15,300 | 15,300 | - | - | Option (right to buy) | |
| NewAmsterdam Pharma Co NV | John W. Smither | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 15,300 | 15,300 | - | - | Option (right to buy) | |
| NewAmsterdam Pharma Co NV | Adele M. Gulfo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 15,300 | 15,300 | - | - | Option (right to buy) | |
| NewAmsterdam Pharma Co NV | Mark C. McKenna | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 15,300 | 15,300 | - | - | Option (right to buy) | |
| NewAmsterdam Pharma Co NV | Janneke van der Kamp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 15,300 | 15,300 | - | - | Option (right to buy) | |
| Dorian LPG Ltd | John C. Hadjipateras | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 27.30 per share. | 07 Jan 2026 | 15,000 | 153,500 (0%) | 0% | 27.3 | 409,500 | Common Shares, $0.01 par value per share |
| Black Stone Minerals L.P. - Unit | L. Steve Putman | SVP, General Counsel, and Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.38 per share. | 07 Jan 2026 | 14,920 | 682,722 (0%) | 0% | 13.4 | 199,630 | Common units representing limited partner interests |
| Apogee Therapeutics Inc | Carl Dambkowski | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 77.90 per share. | 07 Jan 2026 | 14,820 | 213,449 | - | 77.9 | 1,154,478 | Common Stock |
| Hudson Pacific Properties Inc | Harout K. Diramerian | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 14,810 | 14,810 | - | - | Performance LTIP Units | |
| Two Harbors Investment Corp | Nathan Boucher | EVP General Counsel RoundPoint | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 14,705 | 28,516 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| Infrared Cameras Holdings Inc | Robert Nadolny | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.29 per share. | 07 Jan 2026 | 14,681 | 222,278 | - | 0.3 | 4,257 | Common Stock |
| National Bank Holdings Corp (Class A) | Kirk McLaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 14,645 | 597,831 (1%) | 0% | - | Common Stock | |
| Wynn Resorts | Craig Scott Billings | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 14,533 | 218,542 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| AnaptysBio Inc | Daniel R. Faga | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 44.71 per share. | 07 Jan 2026 | 14,281 | 479,344 (1%) | 0% | 44.7 | 638,504 | Common Stock |
| Fennec Pharma Inc | Robert Andrade | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.45 per share. | 07 Jan 2026 | 14,184 | 191,100 (0%) | 0% | 2.5 | 34,751 | Common shares |
| Fennec Pharma Inc | Robert Andrade | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 14,184 | 836,567 | - | - | Stock Options | |
| Wynn Resorts | Craig Scott Billings | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 14,093 | 14,093 | - | - | Performance Share Units | |
| Apogee Therapeutics Inc | Carl Dambkowski | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 14,025 | 139,540 | - | - | Stock Option (Right to Buy) | |
| Apogee Therapeutics Inc | Carl Dambkowski | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.86 per share. | 07 Jan 2026 | 14,025 | 231,223 | - | 22.9 | 320,612 | Common Stock |
| Watsco Inc (Class A) | Aaron J. Nahmad | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 13,955 | 305,993 | - | - | Class B Common stock | |
| Live Nation Entertainment | Joe Berchtold | President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 143.96 per share. | 07 Jan 2026 | 13,755 | 953,280 (0%) | 0% | 144.0 | 1,980,170 | Common Stock |
| Gaming and Leisure Properties Inc | Steven L. Ladany | SVP Chief Development Officer | Sale of securities on an exchange or to another person at price $ 45.04 per share. | 07 Jan 2026 | 13,409 | 57,886 (0%) | 0% | 45.0 | 603,941 | Common Stock |
| Flywire Corp | Peter Butterfield | General Counsel and CCO | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 07 Jan 2026 | 13,327 | 374,933 | - | 15.0 | 200,073 | Voting Common Stock |
| Cidara Therapeutics Inc | Jeffrey Stein | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 13,249 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Nicole Negar Davarpanah | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 221.50 per share. | 07 Jan 2026 | 12,553 | 8,333 (0%) | 0% | 221.5 | 2,780,490 | Common Stock |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 12,500 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 12,499 | 0 | - | - | Employee Stock Option (right to buy) | |
| Tilray Brands Inc | Steven M. Cohen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.99 per share. | 07 Jan 2026 | 12,438 | 12,438 | - | 9.0 | 111,818 | Common Stock |
| Tilray Brands Inc | Steven M. Cohen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 12,438 | 0 | - | - | Restricted Stock Units | |
| Wynn Resorts | Craig Scott Billings | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 116.37 per share. | 07 Jan 2026 | 11,928 | 282,950 (0%) | 0% | 116.4 | 1,388,061 | Common Stock, par value $0.01 per share |
| Cidara Therapeutics Inc | Jeffrey Stein | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 11,749 | 0 | - | - | Employee Stock Option (right to buy) | |
| NewAmsterdam Pharma Co NV | Michael Harvey Davidson | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 07 Jan 2026 | 11,582 | 378,859 | - | - | Ordinary Shares | |
| Cidara Therapeutics Inc | Daniel D. Burgess | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 11,100 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Theodore R. Schroeder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 11,100 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Chrysa Mineo | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 11,100 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Bonnie L. Bassler | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 11,100 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Ryan Spencer | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 11,100 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Carin Canale-Theakston | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 11,100 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | James Merson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 11,100 | 0 | - | - | Stock Option (right to buy) | |
| Roblox Corp (Class A) | David Baszucki | Director, President & CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 76.22 per share. | 07 Jan 2026 | 11,088 | 884,750 | - | 76.2 | 845,086 | Class A Common Stock |
| Cidara Therapeutics Inc | Jeffrey Stein | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 11,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Nicole Negar Davarpanah | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 11,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Figs Inc (Class A) | Sarah Oughtred | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 11.50 per share. | 07 Jan 2026 | 10,515 | 834,830 | - | 11.5 | 120,927 | Class A Common Stock |
| KLX Energy Services Holdings Inc | Keefer M. Lehner | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 10,148 | 0 | - | - | Restricted Stock Unit | |
| Calix Inc | Carl Russo | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.63 per share. | 07 Jan 2026 | 10,000 | 3,983,070 (7%) | 0% | 12.6 | 126,300 | Common Stock |
| Calix Inc | Carl Russo | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 10,000 | 570,000 | - | - | Stock Option (right to buy) | |
| Argan Inc | William F. Leimkuhler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 10,000 | 21,500 | - | - | Option to Purchase Common Stock | |
| Argan Inc | William F. Leimkuhler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 10,000 | 11,500 | - | - | Option to Purchase Common Stock | |
| Vericel Corp | Michael Halpin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.66 per share. | 07 Jan 2026 | 10,000 | 26,080 (0%) | 0% | 16.7 | 166,600 | Common Stock |
| Vericel Corp | Michael Halpin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 40.48 per share. | 07 Jan 2026 | 10,000 | 16,080 (0%) | 0% | 40.5 | 404,800 | Common Stock |
| Vericel Corp | Michael Halpin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 10,000 | 46,250 | - | - | Stock Option (Right to Buy) | |
| Photronics Inc | Kang Jyh Lee | Director | Sale of securities on an exchange or to another person at price $ 34.83 per share. | 07 Jan 2026 | 10,000 | 445,850 (0%) | 0% | 34.8 | 348,300 | COMMON STOCK |
| Revolution Medicines Inc | Jack Anders | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 98.00 per share. | 07 Jan 2026 | 10,000 | 108,065 (0%) | 0% | 98 | 980,000 | Common Stock |
| Revolution Medicines Inc | Jack Anders | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 10,000 | 15,900 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Jack Anders | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.45 per share. | 07 Jan 2026 | 10,000 | 118,065 (0%) | 0% | 42.5 | 424,500 | Common Stock |
| enCore Energy Corp | William M. Sheriff | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 2.81 per share. | 07 Jan 2026 | 10,000 | 2,876 | - | 2.8 | 28,100 | Common Stock |
| Roblox Corp (Class A) | David Baszucki | Director, President & CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 76.78 per share. | 07 Jan 2026 | 9,684 | 875,066 | - | 76.8 | 743,556 | Class A Common Stock |
| Two Harbors Investment Corp | Jillian Halm | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 9,337 | 19,109 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| Alphabet (Class A) | Sundar Pichai | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 322.11 per share. | 07 Jan 2026 | 9,280 | 2,249,131 (0%) | 0% | 322.1 | 2,989,181 | Class C Capital Stock |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 9,264 | 9,262 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Sale of securities on an exchange or to another person at price $ 84.62 per share. | 07 Jan 2026 | 9,264 | 17,494 (0%) | 0% | 84.6 | 783,920 | Common Stock |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.87 per share. | 07 Jan 2026 | 9,264 | 26,758 (0%) | 0% | 52.9 | 489,788 | Common Stock |
| Alphabet (Class A) | Sundar Pichai | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 320.10 per share. | 07 Jan 2026 | 9,079 | 2,264,693 (0%) | 0% | 320.1 | 2,906,188 | Class C Capital Stock |
| Kilroy Realty Corp | Jeffrey Kuehling | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.82 per share. | 07 Jan 2026 | 8,906 | 19,036 (0%) | 0% | 39.8 | 354,637 | Common stock, par value $0.01 per share |
| Argan Inc | William F. Leimkuhler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.15 per share. | 07 Jan 2026 | 8,794 | 49,828 (0%) | 0% | 40.1 | 353,079 | Common Stock |
| Argan Inc | William F. Leimkuhler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.75 per share. | 07 Jan 2026 | 8,626 | 58,454 (0%) | 0% | 45.8 | 394,640 | Common Stock |
| Avidity Biosciences Inc | Sarah Boyce | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 72.23 per share. | 07 Jan 2026 | 8,576 | 283,394 | - | 72.2 | 619,444 | Common Stock |
| AnaptysBio Inc | Paul F. Lizzul | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 8,525 | 25,575 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Paul F. Lizzul | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 8,525 | 45,738 (0%) | 0% | - | Common Stock | |
| Cidara Therapeutics Inc | Nicole Negar Davarpanah | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 8,333 | 0 (0%) | 0% | - | Common Stock | |
| Cidara Therapeutics Inc | Jeffrey Stein | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 7,949 | 0 | - | - | Employee Stock Option (right to buy) | |
| Urban Outfitters Inc | Richard A. Hayne | Director, CEO & Chairman of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 79.71 per share. | 07 Jan 2026 | 7,924 | 17,720,169 (18%) | 0% | 79.7 | 631,606 | Common Shares |
| Oklo Inc (Class A) | Jacob DeWitte | Director, Co-Founder, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 99.49 per share. | 07 Jan 2026 | 7,597 | 836,192 | - | 99.5 | 755,794 | Class A Common Stock |
| Oklo Inc (Class A) | Caroline Cochran | Director, Co-Founder, COO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 99.49 per share. | 07 Jan 2026 | 7,597 | 836,192 | - | 99.5 | 755,794 | Class A Common Stock |
| Oklo Inc (Class A) | Jacob DeWitte | Director, Co-Founder, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 99.49 per share. | 07 Jan 2026 | 7,596 | 827,019 | - | 99.5 | 755,694 | Class A Common Stock |
| Oklo Inc (Class A) | Caroline Cochran | Director, Co-Founder, COO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 99.49 per share. | 07 Jan 2026 | 7,596 | 827,019 | - | 99.5 | 755,694 | Class A Common Stock |
| Cidara Therapeutics Inc | Frank L. Karbe | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 221.50 per share. | 07 Jan 2026 | 7,526 | 43,125 (0%) | 0% | 221.5 | 1,667,009 | Common Stock |
| MeiraGTx Holdings PLC | Robert J. Wollin | GENERAL COUNSEL AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 7,500 | 33,646 (0%) | 0% | - | Ordinary Shares | |
| MeiraGTx Holdings PLC | Robert J. Wollin | GENERAL COUNSEL AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 7,500 | 0 | - | - | Restricted Share Units | |
| Argan Inc | Peter W. Getsinger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 7,500 | 14,000 | - | - | Option to Purchase Common Stock | |
| Kilroy Realty Corp | Angela M. Aman | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.82 per share. | 07 Jan 2026 | 7,458 | 104,849 (0%) | 0% | 39.8 | 296,978 | Common stock, par value $0.01 per share |
| NRG Energy | Woo-Sung Bruce Chung | EVP & CFO | Sale of securities on an exchange or to another person at price $ 158.79 per share. | 07 Jan 2026 | 7,383 | 79,147 (0%) | 0% | 158.8 | 1,172,374 | Common Stock, par value $.01 per share |
| Terreno Realty Corp | John T. Meyer | EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 7,127 | 127,076 (0%) | 0% | 0 | Common Stock, $0.01 par value per share | |
| Bitcoin Depot Inc (Class A) | Scott Buchanan | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.29 per share. | 07 Jan 2026 | 7,000 | 612,276 | - | 1.3 | 9,030 | Class A Common Stock |
| Urban Outfitters Inc | Margaret A. Hayne | Director, Co-President & CCO | Sale of securities on an exchange or to another person at price $ 79.71 per share. | 07 Jan 2026 | 6,934 | 2,170,774 (2%) | 0% | 79.7 | 552,695 | Common Shares |
| Urban Outfitters Inc | Richard A. Hayne | Director, CEO & Chairman of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 79.71 per share. | 07 Jan 2026 | 6,934 | 2,170,774 (2%) | 0% | 79.7 | 552,695 | Common Shares |
| Everspin Tech Inc | William Cooper | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.06 per share. | 07 Jan 2026 | 6,807 | 93,193 (0%) | 0% | 12.1 | 82,092 | Common Stock |
| MeiraGTx Holdings PLC | Robert K. Zeldin | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.73 per share. | 07 Jan 2026 | 6,729 | 147,291 (0%) | 0% | 7.7 | 52,015 | Ordinary Shares |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 6,700 | 24,367 (0%) | 0% | - | Common Stock | |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 6,700 | 20,100 | - | - | Restricted Stock Unit | |
| Argan Inc | Peter W. Getsinger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.15 per share. | 07 Jan 2026 | 6,595 | 14,442 (0%) | 0% | 40.1 | 264,789 | Common Stock |
| Argan Inc | Peter W. Getsinger | Director | Sale of securities on an exchange or to another person at price $ 313.71 per share. | 07 Jan 2026 | 6,595 | 7,847 (0%) | 0% | 313.7 | 2,068,917 | Common Stock |
| Equillium Inc | Penny Tom | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 1.29 per share. | 07 Jan 2026 | 6,533 | 0 (0%) | 0% | 1.3 | 8,428 | Common Stock |
| Acumen Pharma Inc | James J. Doherty | President and CDO | Sale of securities on an exchange or to another person at price $ 1.82 per share. | 07 Jan 2026 | 6,467 | 54,033 | - | 1.8 | 11,769 | Common Stock |
| Wynn Resorts | Julie M. Cameron-Doe | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 6,429 | 38,558 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Guardant Health Inc | Terilyn Juarez Monroe | Chief People Officer | Sale of securities on an exchange or to another person at price $ 111.75 per share. | 07 Jan 2026 | 6,311 | 24,710 (0%) | 0% | 111.8 | 705,268 | Common Stock |
| Alphabet (Class A) | Sundar Pichai | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 321.21 per share. | 07 Jan 2026 | 6,282 | 2,258,411 (0%) | 0% | 321.2 | 2,017,841 | Class C Capital Stock |
| Reddit Inc (Class A) | Benjamin Lee | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 260.00 per share. | 07 Jan 2026 | 6,250 | 62,608 | - | 260 | 1,625,000 | Class A Common Stock |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 6,207 | 0 | - | - | Employee Stock Option (right to buy) | |
| AnaptysBio Inc | Eric J. Loumeau | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 5,888 | 15,045 (0%) | 0% | - | Common Stock | |
| AnaptysBio Inc | Eric J. Loumeau | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 5,888 | 17,662 | - | - | Restricted Stock Unit | |
| Wynn Resorts | Craig Scott Billings | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 116.37 per share. | 07 Jan 2026 | 5,871 | 294,878 (0%) | 0% | 116.4 | 683,208 | Common Stock, par value $0.01 per share |
| Arteris Inc | Nicholas B. Hawkins | VP and Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.27 per share. | 07 Jan 2026 | 5,836 | 82,267 | - | 17.3 | 100,799 | Common Stock |
| Wynn Resorts | Julie M. Cameron-Doe | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 5,789 | 49,348 (0%) | 0% | - | Common Stock, par value $0.01 per share | |
| Cidara Therapeutics Inc | Jeffrey Stein | Director, President & CEO | Sale or transfer of securities back to the company at price $ 221.50 per share. | 07 Jan 2026 | 5,763 | 0 (0%) | 0% | 221.5 | 1,276,505 | Common Stock |
| Terreno Realty Corp | Jaime J. Cannon | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 5,757 | 117,038 (0%) | 0% | 0 | Common Stock, $0.01 par value per share | |
| EverQuote Inc (Class A) | David Brainard | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 25.05 per share. | 07 Jan 2026 | 5,709 | 101,603 (0%) | 0% | 25.0 | 143,010 | Class A Common Stock |
| Oklo Inc (Class A) | Jacob DeWitte | Director, Co-Founder, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 96.99 per share. | 07 Jan 2026 | 5,609 | 904,693 | - | 97.0 | 544,016 | Class A Common Stock |
| Oklo Inc (Class A) | Caroline Cochran | Director, Co-Founder, COO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 96.99 per share. | 07 Jan 2026 | 5,609 | 904,693 | - | 97.0 | 544,016 | Class A Common Stock |
| Oklo Inc (Class A) | Jacob DeWitte | Director, Co-Founder, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 96.99 per share. | 07 Jan 2026 | 5,608 | 913,867 | - | 97.0 | 543,919 | Class A Common Stock |
| Oklo Inc (Class A) | Caroline Cochran | Director, Co-Founder, COO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 96.99 per share. | 07 Jan 2026 | 5,608 | 913,867 | - | 97.0 | 543,919 | Class A Common Stock |
| Wynn Resorts | Julie M. Cameron-Doe | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 5,522 | 33,540 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Black Stone Minerals L.P. - Unit | H. Taylor DeWalch | Director, Co-CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.38 per share. | 07 Jan 2026 | 5,458 | 59,783 (0%) | 0% | 13.4 | 73,028 | Common units representing limited partner interests |
| Wynn Resorts | Craig Scott Billings | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 117.83 per share. | 07 Jan 2026 | 5,081 | 277,869 (0%) | 0% | 117.8 | 598,694 | Common Stock, par value $0.01 per share |
| Wynn Resorts | Julie M. Cameron-Doe | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 5,001 | 43,559 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Cidara Therapeutics Inc | Nicole Negar Davarpanah | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 5,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| NRG Energy | Woo-Sung Bruce Chung | EVP & CFO | Sale of securities on an exchange or to another person at price $ 153.25 per share. | 07 Jan 2026 | 5,000 | 86,530 (0%) | 0% | 153.3 | 766,258 | Common Stock, par value $.01 per share |
| EverCommerce Inc | Matthew David Feiersrtein | President | Sale of securities on an exchange or to another person at price $ 12.10 per share. | 07 Jan 2026 | 5,000 | 2,065,919 | - | 12.1 | 60,510 | Common Stock |
| Argan Inc | William F. Leimkuhler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 5,000 | 6,500 | - | - | Option to Purchase Common Stock | |
| Argan Inc | William F. Leimkuhler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 5,000 | 1,500 | - | - | Option to Purchase Common Stock | |
| ResMed | Michael J. Farrell | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.34 per share. | 07 Jan 2026 | 4,991 | 471,214 (0%) | 0% | 146.3 | 730,383 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 248.46 per share. | 07 Jan 2026 | 4,991 | 466,223 (0%) | 0% | 248.5 | 1,240,065 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 4,991 | 49,912 | - | - | ResMed Common Stock Options | |
| Kilroy Realty Corp | A. Robert Paratte | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.82 per share. | 07 Jan 2026 | 4,960 | 79,792 (0%) | 0% | 39.8 | 197,507 | Common stock, par value $0.01 per share |
| Wynn Resorts | Jacqui Krum | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 4,796 | 46,864 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Codexis Inc | Stefan Lutz | CSO | Sale of securities on an exchange or to another person at price $ 1.70 per share. | 07 Jan 2026 | 4,685 | 138,775 (0%) | 0% | 1.7 | 7,950 | Common Stock |
| Aqua Metals Inc | Stephen Cotton | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 4,530 | 0 | - | - | Performance Share Units | |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 474.99 per share. | 07 Jan 2026 | 4,500 | 42,293 (0%) | 0% | 475.0 | 2,137,455 | Common Stock |
| Wynn Resorts | Craig Scott Billings | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 116.37 per share. | 07 Jan 2026 | 4,478 | 214,064 (0%) | 0% | 116.4 | 521,105 | Common Stock, par value $0.01 per share |
| Argan Inc | William F. Leimkuhler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.72 per share. | 07 Jan 2026 | 4,463 | 67,359 (0%) | 0% | 35.7 | 159,418 | Common Stock |
| Argan Inc | William F. Leimkuhler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.13 per share. | 07 Jan 2026 | 4,442 | 62,896 (0%) | 0% | 37.1 | 164,931 | Common Stock |
| Urban Outfitters Inc | Richard A. Hayne | Director, CEO & Chairman of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 83.32 per share. | 07 Jan 2026 | 4,434 | 17,708,089 (18%) | 0% | 83.3 | 369,454 | Common Shares |
| GigaCloud Tech Inc (Class A) | Larry Lei Wu | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 41.95 per share. | 07 Jan 2026 | 4,421 | 855,579 | - | 42.0 | 185,465 | Class A Ordinary Shares, par value $0.05 per share |
| Oklo Inc (Class A) | Jacob DeWitte | Director, Co-Founder, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 95.76 per share. | 07 Jan 2026 | 4,387 | 919,475 | - | 95.8 | 420,096 | Class A Common Stock |
| Oklo Inc (Class A) | Caroline Cochran | Director, Co-Founder, COO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 95.76 per share. | 07 Jan 2026 | 4,387 | 919,475 | - | 95.8 | 420,096 | Class A Common Stock |
| Oklo Inc (Class A) | Jacob DeWitte | Director, Co-Founder, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 95.76 per share. | 07 Jan 2026 | 4,386 | 910,302 | - | 95.8 | 420,000 | Class A Common Stock |
| Oklo Inc (Class A) | Caroline Cochran | Director, Co-Founder, COO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 95.76 per share. | 07 Jan 2026 | 4,386 | 910,302 | - | 95.8 | 420,000 | Class A Common Stock |
| MeiraGTx Holdings PLC | Robert J. Wollin | GENERAL COUNSEL AND SECRETARY | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.73 per share. | 07 Jan 2026 | 4,364 | 29,282 (0%) | 0% | 7.7 | 33,734 | Ordinary Shares |
| Wynn Resorts | Jacqui Krum | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 4,307 | 49,934 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Cidara Therapeutics Inc | Ryan Spencer | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 4,250 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | James Merson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 4,250 | 0 | - | - | Stock Option (right to buy) | |
| Credo Tech Grp Holding Ltd | Daniel Fleming | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 128.10 per share. | 07 Jan 2026 | 4,136 | 450,604 | - | 128.1 | 529,812 | Ordinary Shares |
| Live Nation Entertainment | John Hopmans | EVP, M&A and Strategic Finance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 143.96 per share. | 07 Jan 2026 | 4,040 | 202,959 (0%) | 0% | 144.0 | 581,598 | Common Stock |
| Argan Inc | Peter W. Getsinger | Director | Sale of securities on an exchange or to another person at price $ 328.34 per share. | 07 Jan 2026 | 4,000 | 7,847 (0%) | 0% | 328.3 | 1,313,360 | Common Stock |
| Wynn Resorts | Julie M. Cameron-Doe | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 3,994 | 0 | - | - | Performance Share Units | |
| Credo Tech Grp Holding Ltd | Daniel Fleming | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 140.15 per share. | 07 Jan 2026 | 3,902 | 446,178 | - | 140.2 | 546,867 | Ordinary Shares |
| Invesco Quality Municipal Income Trust | Jack Connelly | Portfolio Manager | Sale of securities on an exchange or to another person at price $ 10.02 per share. | 07 Jan 2026 | 3,900 | 5,500 (0%) | 0% | 10.0 | 39,078 | Common Shares |
| Urban Outfitters Inc | Margaret A. Hayne | Director, Co-President & CCO | Sale of securities on an exchange or to another person at price $ 83.32 per share. | 07 Jan 2026 | 3,881 | 2,160,205 (2%) | 0% | 83.3 | 323,377 | Common Shares |
| Urban Outfitters Inc | Richard A. Hayne | Director, CEO & Chairman of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 83.32 per share. | 07 Jan 2026 | 3,881 | 2,160,205 (2%) | 0% | 83.3 | 323,377 | Common Shares |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 3,829 | 9,254 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Sale of securities on an exchange or to another person at price $ 84.62 per share. | 07 Jan 2026 | 3,829 | 17,494 (0%) | 0% | 84.6 | 324,010 | Common Stock |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.58 per share. | 07 Jan 2026 | 3,829 | 21,323 (0%) | 0% | 37.6 | 143,894 | Common Stock |
| Kilroy Realty Corp | Eliott Trencher | EVP, Chief Investment Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.82 per share. | 07 Jan 2026 | 3,796 | 40,559 (0%) | 0% | 39.8 | 151,157 | Common stock, par value $0.01 per share |
| Urban Outfitters Inc | Richard A. Hayne | Director, CEO & Chairman of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 82.65 per share. | 07 Jan 2026 | 3,742 | 17,712,523 (18%) | 0% | 82.6 | 309,258 | Common Shares |
| Dover | James M. Moran | VP & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.28 per share. | 07 Jan 2026 | 3,728 | 11,707 (0%) | 0% | 48.3 | 179,988 | Common Stock |
| Dover | James M. Moran | VP & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 3,728 | 0 | - | - | Stock appreciation right (right to acquire) | |
| Avidity Biosciences Inc | Charles Calderaro | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 72.23 per share. | 07 Jan 2026 | 3,727 | 49,797 | - | 72.2 | 269,201 | Common Stock |
| Monte Rosa Therapeutics Inc | Markus Warmuth | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 23.24 per share. | 07 Jan 2026 | 3,707 | 620,696 | - | 23.2 | 86,159 | Common Stock |
| AnaptysBio Inc | Paul F. Lizzul | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 44.71 per share. | 07 Jan 2026 | 3,650 | 42,088 (0%) | 0% | 44.7 | 163,192 | Common Stock |
| Guardant Health Inc | Terilyn Juarez Monroe | Chief People Officer | Sale of securities on an exchange or to another person at price $ 112.62 per share. | 07 Jan 2026 | 3,632 | 21,078 (0%) | 0% | 112.6 | 409,029 | Common Stock |
| Semtech Corp | Saar Gillai | Director | Sale of securities on an exchange or to another person at price $ 75.26 per share. | 07 Jan 2026 | 3,600 | 9,523 (0%) | 0% | 75.3 | 270,945 | Common Stock |
| National Bank Holdings Corp (Class A) | Kirk McLaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 3,530 | 3,530 (0%) | 0% | - | Common Stock | |
| Greenbrier Cos. Inc | Graeme Allan Jack | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 3,465 | 49,919 | - | - | Phantom Shares | |
| Greenbrier Cos. Inc | Thomas B. Fargo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 3,465 | 33,975 | - | - | Phantom Shares | |
| Greenbrier Cos. Inc | Wendy L. Teramoto | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 3,465 | 37,832 (0%) | 0% | 0 | Common Stock | |
| Greenbrier Cos. Inc | Antonio O. Garza | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 3,465 | 27,196 (0%) | 0% | 0 | Common Stock | |
| Greenbrier Cos. Inc | James R. Huffines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 3,465 | 17,592 | - | - | Phantom Shares | |
| Greenbrier Cos. Inc | Jeffrey Mark Songer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 3,465 | 5,241 | - | - | Phantom Shares | |
| Greenbrier Cos. Inc | Kelly M. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 3,465 | 39,843 | - | - | Phantom Shares | |
| Greenbrier Cos. Inc | Stevan B. Bobb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 3,465 | 5,241 | - | - | Phantom Shares | |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 3,460 | 7,879 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Sale of securities on an exchange or to another person at price $ 84.62 per share. | 07 Jan 2026 | 3,460 | 17,494 (0%) | 0% | 84.6 | 292,785 | Common Stock |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.60 per share. | 07 Jan 2026 | 3,460 | 20,954 (0%) | 0% | 32.6 | 112,796 | Common Stock |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 3,458 | 97,019 | - | - | Share Option (Right to Buy) | |
| NewAmsterdam Pharma Co NV | Louis G. Lange | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 3,400 | 10,360 | - | - | Ordinary Shares | |
| NewAmsterdam Pharma Co NV | William H. Lewis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 3,400 | 10,360 | - | - | Ordinary Shares | |
| NewAmsterdam Pharma Co NV | John W. Smither | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 3,400 | 10,360 | - | - | Ordinary Shares | |
| NewAmsterdam Pharma Co NV | Adele M. Gulfo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 3,400 | 14,260 | - | - | Ordinary Shares | |
| NewAmsterdam Pharma Co NV | Mark C. McKenna | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 3,400 | 10,360 | - | - | Ordinary Shares | |
| NewAmsterdam Pharma Co NV | Janneke van der Kamp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 3,400 | 10,360 | - | - | Ordinary Shares | |
| Wynn Resorts | Jacqui Krum | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 3,350 | 53,284 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Kratos Defense & Security Soln Inc | Thomas E. Mills | President, C5ISR Division | Sale of securities on an exchange or to another person at price $ 91.65 per share. | 07 Jan 2026 | 3,323 | 15,002 (0%) | 0% | 91.7 | 304,561 | Common Stock |
| Cidara Therapeutics Inc | Chrysa Mineo | Director | Sale or transfer of securities back to the company at price $ 221.50 per share. | 07 Jan 2026 | 3,320 | 0 (0%) | 0% | 221.5 | 735,380 | Common Stock |
| Reddit Inc (Class A) | Benjamin Lee | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 3,320 | 149,500 | - | - | Stock Option (Right to Buy) | |
| Reddit Inc (Class A) | Benjamin Lee | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 260.22 per share. | 07 Jan 2026 | 3,320 | 62,608 | - | 260.2 | 863,930 | Class A Common Stock |
| Reddit Inc (Class A) | Benjamin Lee | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.92 per share. | 07 Jan 2026 | 3,320 | 65,928 | - | 7.9 | 26,294 | Class A Common Stock |
| Urban Outfitters Inc | Margaret A. Hayne | Director, Co-President & CCO | Sale of securities on an exchange or to another person at price $ 82.65 per share. | 07 Jan 2026 | 3,274 | 2,164,086 (2%) | 0% | 82.6 | 270,580 | Common Shares |
| Urban Outfitters Inc | Richard A. Hayne | Director, CEO & Chairman of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 82.65 per share. | 07 Jan 2026 | 3,274 | 2,164,086 (2%) | 0% | 82.6 | 270,580 | Common Shares |
| Kilroy Realty Corp | Justin William Smart | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 3,256 | 379,779 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| Oklo Inc (Class A) | Jacob DeWitte | Director, Co-Founder, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 93.79 per share. | 07 Jan 2026 | 3,121 | 915,902 | - | 93.8 | 292,710 | Class A Common Stock |
| Oklo Inc (Class A) | Jacob DeWitte | Director, Co-Founder, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 93.79 per share. | 07 Jan 2026 | 3,121 | 925,076 | - | 93.8 | 292,710 | Class A Common Stock |
| Oklo Inc (Class A) | Caroline Cochran | Director, Co-Founder, COO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 93.79 per share. | 07 Jan 2026 | 3,121 | 925,076 | - | 93.8 | 292,710 | Class A Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.